{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:37:16Z","timestamp":1753439836496,"version":"3.40.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["UGC-CAS II"],"award-info":[{"award-number":["UGC-CAS II"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10787-025-01682-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:36:24Z","timestamp":1740724584000},"page":"1357-1379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gefitinib as an antimalarial: unveiling its therapeutic potential"],"prefix":"10.1007","volume":"33","author":[{"given":"Varun","family":"Gorki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha Sylvia","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelima","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upma","family":"Bagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-7950","authenticated-orcid":false,"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"9402","key":"1682_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0140-6736(03)15162-8","volume":"363","author":"M Adjuik","year":"2004","unstructured":"Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N, International Artemisinin Study Group (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363(9402):9\u201317. https:\/\/doi.org\/10.1016\/s0140-6736(03)15162-8","journal-title":"Lancet"},{"key":"1682_CR2","doi-asserted-by":"publisher","first-page":"5954394","DOI":"10.1155\/2016\/5954394","volume":"2016","author":"M Al-Salahy","year":"2016","unstructured":"Al-Salahy M, Shnawa B, Abed G, Mandour A, Al-Ezzi A (2016) Parasitaemia and its relation to hematological parameters and liver function among patients malaria in Abs, Hajjah. Northwest Yemen Interdiscip Perspect Infect Dis 2016:5954394. https:\/\/doi.org\/10.1155\/2016\/5954394","journal-title":"Northwest Yemen Interdiscip Perspect Infect Dis"},{"key":"1682_CR3","first-page":"155","volume-title":"Cytological technique","author":"JR Baker","year":"1946","unstructured":"Baker JR (1946) Histochemical analysis. In: Abercrombie M (ed) Cytological technique, 2nd edn. Metheren and Co., Pub, London, pp 155\u2013162","edition":"2"},{"issue":"5","key":"1682_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4269\/ajtmh.2008.78.721","volume":"78","author":"A Bhattacharya","year":"2008","unstructured":"Bhattacharya A, Mishra LC, Bhasin VK (2008) In vitro activity of artemisinin in combination with clotrimazole or heat-treated amphotericin B against Plasmodium falciparum. Am J Trop Med Hyg 78(5):721\u2013728","journal-title":"Am J Trop Med Hyg"},{"issue":"1\u20132","key":"1682_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbapap.2003.11.021","volume":"1697","author":"C Doerig","year":"2004","unstructured":"Doerig C (2004) Protein kinases as targets for anti-parasitic chemotherapy. Biochim Biophys Acta 1697(1\u20132):155\u2013168. https:\/\/doi.org\/10.1016\/j.bbapap.2003.11.021","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1682_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/s1471-4922(02)02321-8","volume":"18","author":"C Doerig","year":"2002","unstructured":"Doerig C, Meijer L, Mottram JC (2002) Protein kinases as drug targets in parasitic protozoa. Trends Parasitol 18(8):366\u2013371. https:\/\/doi.org\/10.1016\/s1471-4922(02)02321-8","journal-title":"Trends Parasitol"},{"issue":"12","key":"1682_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.pt.2008.08.007","volume":"24","author":"C Doerig","year":"2008","unstructured":"Doerig C, Billker O, Haystead T, Sharma P, Tobin AB, Waters NC (2008) Protein kinases of malaria parasites: an update. Trends Parasitol 24(12):570\u2013577. https:\/\/doi.org\/10.1016\/j.pt.2008.08.007","journal-title":"Trends Parasitol"},{"issue":"8","key":"1682_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","volume":"37","author":"M Duffey","year":"2021","unstructured":"Duffey M, Blasco B, Burrows JN, Wells TNC, Fidock DA, Leroy D (2021) Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials. Trends Parasitol 37(8):709\u2013721. https:\/\/doi.org\/10.1016\/j.pt.2021.04.006","journal-title":"Trends Parasitol"},{"key":"1682_CR9","unstructured":"EPA (U.S. Environmental Protection Agency). 1998. Health Effects Test Guidelines OPPTS 870.1000. Acute Toxicity Testing-Background. EPA 712-C-98\u2013189. Office of Prevention, Pesticides, and Toxic Substances, U.S. Environmental Protection Agency, Washington, DC. Series 870 - Health Effects Test Guidelines | US EPA"},{"issue":"1","key":"1682_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12936-017-2148-6","volume":"16","author":"L Farrington","year":"2017","unstructured":"Farrington L, Vance H, Rek J, Prahl M, Jagannathan P, Katureebe A et al (2017) Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children. Malar J 16(1):499. https:\/\/doi.org\/10.1186\/s12936-017-2148-6","journal-title":"Malar J"},{"key":"1682_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpddr.2020.12.001","volume":"15","author":"MU Ferreira","year":"2021","unstructured":"Ferreira MU, Nobrega de Sousa T, Rangel GW, Johansen IC, Corder RM, Ladeia-Andrade S, Gil JP (2021) Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions. Int J Parasitol Drugs Drug Resist 15:9\u201324. https:\/\/doi.org\/10.1016\/j.ijpddr.2020.12.001","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"1682_CR12","unstructured":"Food and Drug Administration (FDA). 2003. IRESSA (gefitinib) tablets. Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2003\/021399lbl.pdf (accessed on May 09, 2023)."},{"key":"1682_CR13","unstructured":"Food and Drugs Administration (FDA). 2021. CFR - Code of Federal Regulations, Title 21-Food and drugs, Chapter I--Food and drug administration, Department of Health and Human Services, Subchapter a - general. Part 58. Good laboratory practice for non-clinical laboratory studies. Available online: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=58 (accessed on May 07, 2023)."},{"key":"1682_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.559255","volume":"11","author":"A Frimpong","year":"2020","unstructured":"Frimpong A, Amponsah J, Adjokatseh AS, Agyemang D, Bentum-Ennin L, Ofori EA et al (2020) Asymptomatic malaria infection is maintained by a balanced pro- and anti-inflammatory response. Front Microbiol 11:559255. https:\/\/doi.org\/10.3389\/fmicb.2020.559255","journal-title":"Front Microbiol"},{"issue":"1","key":"1682_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12936-020-03372-9","volume":"19","author":"L Golassa","year":"2020","unstructured":"Golassa L, Amenga-Etego L, Lo E, Amambua-Ngwa A (2020) The biology of unconventional invasion of Duffy-negative reticulocytes by Plasmodium vivax and its implication in malaria epidemiology and public health. Malar J 19(1):299. https:\/\/doi.org\/10.1186\/s12936-020-03372-9","journal-title":"Malar J"},{"issue":"29","key":"1682_CR16","doi-asserted-by":"publisher","first-page":"17993","DOI":"10.1021\/acsomega.0c01256","volume":"5","author":"V Gorki","year":"2020","unstructured":"Gorki V, Walter NS, Singh R, Chauhan M, Dhingra N, Salunke DB et al (2020) \u03b2-Carboline derivatives tackling malaria: Biological evaluation and docking analysis. ACS Omega 5(29):17993\u201318006. https:\/\/doi.org\/10.1021\/acsomega.0c01256","journal-title":"ACS Omega"},{"key":"1682_CR17","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.3389\/fimmu.2018.03006","volume":"9","author":"DC Gowda","year":"2018","unstructured":"Gowda DC, Wu X (2018) Parasite recognition and signaling mechanisms in innate immune responses to malaria. Front Immunol 9:3006. https:\/\/doi.org\/10.3389\/fimmu.2018.03006","journal-title":"Front Immunol"},{"issue":"3","key":"1682_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.lungcan.2010.12.008","volume":"71","author":"C Gridelli","year":"2011","unstructured":"Gridelli C, De Marinis F, Di Maio M, Cortinovis D, Cappuzzo F, Mok T (2011) Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: review of the evidence. Lung Cancer 71(3):249\u2013257. https:\/\/doi.org\/10.1016\/j.lungcan.2010.12.008","journal-title":"Lung Cancer"},{"issue":"9","key":"1682_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","volume":"19","author":"WL Hamilton","year":"2019","unstructured":"Hamilton WL, Amato R, van der Pluijm RW, Jacob CG, Quang HH, Thuy-Nhien NT et al (2019) Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect Dis 19(9):943\u2013951. https:\/\/doi.org\/10.1016\/S1473-3099(19)30392-5","journal-title":"Lancet Infect Dis"},{"key":"1682_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.634690","volume":"9","author":"XM Hu","year":"2021","unstructured":"Hu XM, Li ZX, Lin RH, Shan JQ, Yu QW, Wang RX et al (2021) Guidelines for regulated cell death assays: a systematic summary, a categorical comparison, a prospective. Front Cell Dev Biol 9:634690. https:\/\/doi.org\/10.3389\/fcell.2021.634690","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"1682_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nmeth.1500","volume":"7","author":"JL Hurst","year":"2010","unstructured":"Hurst JL, West RS (2010) Taming anxiety in laboratory mice. Nat Methods 7(10):825\u2013826. https:\/\/doi.org\/10.1038\/nmeth.1500","journal-title":"Nat Methods"},{"key":"1682_CR22","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-9946201759053","volume":"59","author":"SGBD Junior","year":"2017","unstructured":"Junior SGBD, Pinto JR, Barros EJG, Farias GMN, Daher EF (2017) Kidney involvement in malaria: an update. Rev Inst Med Trop Sao Paulo 59:e53. https:\/\/doi.org\/10.1590\/S1678-9946201759053","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1682_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.651739","volume":"12","author":"O Katsoulis","year":"2021","unstructured":"Katsoulis O, Georgiadou A, Cunnington AJ (2021) Immunopathology of acute kidney injury in severe malaria. Front Immunol 12:651739. https:\/\/doi.org\/10.3389\/fimmu.2021.651739","journal-title":"Front Immunol"},{"issue":"10","key":"1682_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164895","volume":"11","author":"KR Kesely","year":"2016","unstructured":"Kesely KR, Pantaleo A, Turrini FM, Olupot-Olupot P, Low PS (2016) Inhibition of an erythrocyte tyrosine kinase with imatinib prevents Plasmodium falciparum egress and terminates parasitemia. PLoS ONE 11(10):e0164895. https:\/\/doi.org\/10.1371\/journal.pone.0164895","journal-title":"PLoS ONE"},{"issue":"4","key":"1682_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/00034983.1980.11687360","volume":"74","author":"DJ Knight","year":"1980","unstructured":"Knight DJ, Peters W (1980) The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Ann Trop Med Parasitol 74(4):393\u2013404","journal-title":"Ann Trop Med Parasitol"},{"key":"1682_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fimmu.2019.00229","volume":"10","author":"R Kumar","year":"2019","unstructured":"Kumar R, Ng S, Engwerda C (2019) The role of IL-10 in malaria: a double edged sword. Front Immunol 10:229. https:\/\/doi.org\/10.3389\/fimmu.2019.00229","journal-title":"Front Immunol"},{"issue":"10","key":"1682_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026689","volume":"6","author":"AN LaCrue","year":"2011","unstructured":"LaCrue AN, Scheel M, Kennedy K, Kumar N, Kyle DE (2011) Effects of artesunate on parasite recrudescence and dormancy in the rodent malaria model Plasmodium vinckei. PLoS ONE 6(10):e26689. https:\/\/doi.org\/10.1371\/journal.pone.0026689","journal-title":"PLoS ONE"},{"issue":"3","key":"1682_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jep.2010.11.056","volume":"133","author":"JB Lekana-Douki","year":"2011","unstructured":"Lekana-Douki JB, Bongui JB, Oyegue Liabagui SL, Zang Edou SE, Zatra R, Bisvigou U et al (2011) In vitro antiplasmodial activity and cytotoxicity of nine plants traditionally used in Gabon. J Ethnopharmacol 133(3):1103\u20131108. https:\/\/doi.org\/10.1016\/j.jep.2010.11.056","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"1682_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"ZJ Li","year":"2021","unstructured":"Li ZJ, Dai HQ, Huang XW, Feng J, Deng JH, Wang ZX et al (2021) Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin 42(2):301\u2013310. https:\/\/doi.org\/10.1038\/s41401-020-0478-3","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"1682_CR30","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/IAI.02796-14","volume":"Mar","author":"P Liehl","year":"2015","unstructured":"Liehl P, Meireles P, Albuquerque IS, Pinkevych M, Baptista F, Mota MM et al (2015) Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections. Infect Immun Mar(3):1172\u20131180. https:\/\/doi.org\/10.1128\/IAI.02796-14","journal-title":"Infect Immun"},{"issue":"3","key":"1682_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1039\/c2an15780b","volume":"137","author":"L Liu","year":"2012","unstructured":"Liu L, Mo H, Wei S, Raftery D (2012) Quantitative analysis of urea in human urine and serum by 1H nuclear magnetic resonance. Analyst 137(3):595\u2013600. https:\/\/doi.org\/10.1039\/c2an15780b","journal-title":"Analyst"},{"issue":"4","key":"1682_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF01234480","volume":"54","author":"D Lorke","year":"1983","unstructured":"Lorke D (1983) A new approach to practical acute toxicity testing. Arch Toxicol 54(4):275\u2013287. https:\/\/doi.org\/10.1007\/BF01234480","journal-title":"Arch Toxicol"},{"issue":"12","key":"1682_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.07.004","volume":"17","author":"C L\u00fcbbert","year":"2013","unstructured":"L\u00fcbbert C, Schubert S (2013) Phagocytosis of a mature schizont in severe falciparum malaria. Int J Infect Dis 17(12):e1265. https:\/\/doi.org\/10.1016\/j.ijid.2013.07.004","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1682_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0022-1759(91)90357-l","volume":"139","author":"P Migliorini","year":"1991","unstructured":"Migliorini P, Corradin G, Corradin SB (1991) Macrophage NO2- production as a sensitive and rapid assay for the quantitation of murine IFN-gamma. J Immunol Methods 139(1):107\u2013114. https:\/\/doi.org\/10.1016\/0022-1759(91)90357-l","journal-title":"J Immunol Methods"},{"issue":"1\u20132","key":"1682_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1\u20132):55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"issue":"2","key":"1682_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0378-8741(99)00096-3","volume":"69","author":"V Mu\u00f1oz","year":"2000","unstructured":"Mu\u00f1oz V, Sauvain M, Bourdy G, Callapa J, Rojas I, Vargas L et al (2000) The search for natural bioactive compounds through a multidisciplinary approach in Bolivia. Part II. Antimalarial activity of some plants used by Mosetene indians. J Ethnopharmacol 69(2):139\u2013155. https:\/\/doi.org\/10.1016\/s0378-8741(99)00096-3","journal-title":"J Ethnopharmacol"},{"key":"1682_CR37","unstructured":"Pearse AGE. 1968. Carbohydrates. In: histochemistry: theoretical and applied (revised edition of Pearse AGE), Churchill A and Churchill J, (ed.). London. pp. 228\u2013280."},{"issue":"1","key":"1682_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/QCO.0000000000000419","volume":"31","author":"K Plewes","year":"2018","unstructured":"Plewes K, Turner GDH, Dondorp AM (2018) Pathophysiology, clinical presentation, and treatment of coma and acute kidney injury complicating falciparum malaria. Curr Opin Infect Dis 31(1):69\u201377. https:\/\/doi.org\/10.1097\/QCO.0000000000000419","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"1682_CR39","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","volume":"14","author":"RN Price","year":"2014","unstructured":"Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ (2014) Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis 14(10):982\u2013991. https:\/\/doi.org\/10.1016\/S1473-3099(14)70855-2","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1682_CR40","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1038\/s41467-022-33403-9","volume":"13","author":"D Qiu","year":"2022","unstructured":"Qiu D, Pei JV, Rosling JEO, Thathy V, Li D, Xue Y et al (2022) A G358S mutation in the Plasmodium falciparum Na+ pump PfATP4 confers clinically-relevant resistance to cipargamin. Nat Commun 13(1):5746. https:\/\/doi.org\/10.1038\/s41467-022-33403-9","journal-title":"Nat Commun"},{"issue":"2","key":"1682_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nm.3083","volume":"19","author":"EM Riley","year":"2013","unstructured":"Riley EM, Stewart VA (2013) Immune mechanisms in malaria: new insights in vaccine development. Nat Med 19(2):168\u2013178. https:\/\/doi.org\/10.1038\/nm.3083","journal-title":"Nat Med"},{"issue":"2","key":"1682_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/00034983.1970.11686683","volume":"64","author":"JF Ryley","year":"1970","unstructured":"Ryley JF, Peters W (1970) The antimalarial activity of some quinolone esters. Ann Trop Med Parasitol 64(2):209\u2013222. https:\/\/doi.org\/10.1080\/00034983.1970.11686683","journal-title":"Ann Trop Med Parasitol"},{"key":"1682_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1475-2875-10-85","volume":"10","author":"SO Sarr","year":"2011","unstructured":"Sarr SO, Perrotey S, Fall I, Ennahar S, Zhao M, Diop YM et al (2011) Icacina senegalensis (Icacinaceae), traditionally used for the treatment of malaria, inhibits in vitro Plasmodium falciparum growth without host cell toxicity. Malar J 10:85. https:\/\/doi.org\/10.1186\/1475-2875-10-85","journal-title":"Malar J"},{"issue":"4","key":"1682_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.tice.2016.04.002","volume":"48","author":"LB Sigola","year":"2016","unstructured":"Sigola LB, Fuentes AL, Millis LM, Vapenik J, Murira A (2016) Effects of Toll-like receptor ligands on RAW 264.7 macrophage morphology and zymosan phagocytosis. Tissue Cell 48(4):389\u2013396. https:\/\/doi.org\/10.1016\/j.tice.2016.04.002","journal-title":"Tissue Cell"},{"issue":"9","key":"1682_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.pt.2005.07.002","volume":"21","author":"P Sobolewski","year":"2005","unstructured":"Sobolewski P, Gramaglia I, Frangos J, Intaglietta M, van der Heyde HC (2005) Nitric oxide bioavailability in malaria. Trends Parasitol 21(9):415\u2013422. https:\/\/doi.org\/10.1016\/j.pt.2005.07.002","journal-title":"Trends Parasitol"},{"issue":"2","key":"1682_CR46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0035-9203(88)90417-8","volume":"82","author":"E Stahel","year":"1988","unstructured":"Stahel E, Druilhe P, Gentilini M (1988) Antagonism of chloroquine with other antimalarials. Trans R Soc Trop Med Hyg 82(2):221. https:\/\/doi.org\/10.1016\/0035-9203(88)90417-8","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"1682_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nri1311","volume":"4","author":"MM Stevenson","year":"2004","unstructured":"Stevenson MM, Riley EM (2004) Innate immunity to malaria. Nat Rev Immunol 4(3):169\u2013180. https:\/\/doi.org\/10.1038\/nri1311","journal-title":"Nat Rev Immunol"},{"issue":"20","key":"1682_CR48","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1158\/0008-5472.CAN-04-0096","volume":"64","author":"CF Stewart","year":"2004","unstructured":"Stewart CF, Leggas M, Schuetz JD, Panetta JC, Cheshire PJ, Peterson J et al (2004) Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice. Cancer Res 64(20):7491\u20137499. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0096","journal-title":"Cancer Res"},{"issue":"656","key":"1682_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn3231","volume":"14","author":"C Swale","year":"2022","unstructured":"Swale C, Bellini V, Bowler MW, Flore N, Brenier-Pinchart MP, Cannella D et al (2022) Altiratinib blocks\u00a0Toxoplasma gondii\u00a0and\u00a0Plasmodium falciparum\u00a0development by selectively targeting a spliceosome kinase. Sci Transl Med 14(656):e3231. https:\/\/doi.org\/10.1126\/scitranslmed.abn3231","journal-title":"Sci Transl Med"},{"issue":"4254","key":"1682_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. Science 193(4254):673\u2013675. https:\/\/doi.org\/10.1126\/science.781840","journal-title":"Science"},{"issue":"1","key":"1682_CR51","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1038\/s41467-022-30990-5","volume":"13","author":"S Uyoga","year":"2022","unstructured":"Uyoga S, Watson JA, Wanjiku P, Rop JC, Makale J, Macharia AW et al (2022) The impact of malaria-protective red blood cell polymorphisms on parasite biomass in children with severe Plasmodium falciparum malaria. Nat Commun 13(1):3307","journal-title":"Nat Commun"},{"issue":"1","key":"1682_CR52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12936-018-2378-2","volume":"17","author":"A Valdes","year":"2018","unstructured":"Valdes A, Epelboin L, Mosnier E, Walter G, Vesin G, Abboud P et al (2018) Primaquine 30 mg\/day versus 15 mg\/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison. Malar J 17(1):237. https:\/\/doi.org\/10.1186\/s12936-018-2378-2","journal-title":"Malar J"},{"issue":"2","key":"1682_CR53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.parint.2016.09.003","volume":"66","author":"E van den Bogaart","year":"2017","unstructured":"van den Bogaart E, Mens PF, Adams ER, Grobusch MP, Schallig HDFH (2017) Phagocytosis of hemozoin by RAW 264.7 cells, but not THP-1 cells, promotes infection by Leishmania donovani with a nitric oxide-independent mechanism. Parasitol Int 66(2):196\u2013206. https:\/\/doi.org\/10.1016\/j.parint.2016.09.003","journal-title":"Parasitol Int"},{"issue":"10233","key":"1682_CR54","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","volume":"395","author":"RW van der Pluijm","year":"2020","unstructured":"van der Pluijm RW, Tripura R, Hoglund RM, Pyae Phyo A, Lek D, Ul Islam A et al (2020) Tracking Resistance to Artemisinin Collaboration. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet 395(10233):1345\u20131360. https:\/\/doi.org\/10.1016\/S0140-6736(20)30552-3","journal-title":"Lancet"},{"issue":"1","key":"1682_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pt.2020.09.011","volume":"37","author":"RW van der Pluijm","year":"2021","unstructured":"van der Pluijm RW, Amaratunga C, Dhorda M, Dondorp AM (2021) Triple artemisinin-based combination therapies for malaria - a new paradigm? Trends Parasitol 37(1):15\u201324. https:\/\/doi.org\/10.1016\/j.pt.2020.09.011","journal-title":"Trends Parasitol"},{"key":"1682_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1475-2875-13-106","volume":"13","author":"P Viriyavejakul","year":"2014","unstructured":"Viriyavejakul P, Khachonsaksumet V, Punsawad C (2014) Liver changes in severe Plasmodium falciparum malaria: histopathology, apoptosis and nuclear factor kappa B expression. Malar J 13:106. https:\/\/doi.org\/10.1186\/1475-2875-13-106","journal-title":"Malar J"},{"issue":"Pt A","key":"1682_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108320","volume":"101","author":"NS Walter","year":"2021","unstructured":"Walter NS, Gorki V, Chauhan M, Dhingra N, Kaur S (2021) Sinigrin in combination with artesunate provides protection against lethal murine malaria via falcipain-3 inhibition and immune modulation. Int Immunopharmacol 101(Pt A):108320. https:\/\/doi.org\/10.1016\/j.intimp.2021.108320","journal-title":"Int Immunopharmacol"},{"key":"1682_CR58","doi-asserted-by":"publisher","first-page":"10111","DOI":"10.1038\/ncomms10111","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, Zhang CJ, Chia WN, Loh CC, Li Z, Lee YM et al (2015) Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat Commun 6:10111. https:\/\/doi.org\/10.1038\/ncomms10111","journal-title":"Nat Commun"},{"issue":"22","key":"1682_CR59","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMp1901233","volume":"380","author":"J Wang","year":"2019","unstructured":"Wang J, Xu C, Liao FL, Jiang T, Krishna S, Tu Y (2019) A temporizing solution to \u201cArtemisinin Resistance.\u201d N Engl J Med 380(22):2087\u20132089. https:\/\/doi.org\/10.1056\/NEJMp1901233","journal-title":"N Engl J Med"},{"key":"1682_CR60","doi-asserted-by":"publisher","first-page":"29151","DOI":"10.1038\/srep29151","volume":"6","author":"JB Weinberg","year":"2016","unstructured":"Weinberg JB, Volkheimer AD, Rubach MP, Florence SM, Mukemba JP, Kalingonji AR et al (2016) Monocyte polarization in children with falciparum malaria: relationship to nitric oxide insufficiency and disease severity. Sci Rep 6:29151. https:\/\/doi.org\/10.1038\/srep29151","journal-title":"Sci Rep"},{"issue":"6","key":"1682_CR61","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1747-0285.2006.00391.x","volume":"67","author":"JL Weisman","year":"2006","unstructured":"Weisman JL, Liou AP, Shelat AA, Cohen FE, Guy RK, DeRisi JL (2006) Searching for new antimalarial therapeutics amongst known drugs. Chem Biol Drug des 67(6):409\u2013416. https:\/\/doi.org\/10.1111\/j.1747-0285.2006.00391.x","journal-title":"Chem Biol Drug des"},{"issue":"9","key":"1682_CR62","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.pt.2020.05.013","volume":"36","author":"TE Wellems","year":"2020","unstructured":"Wellems TE, S\u00e1 JM, Su XZ, Connelly SV, Ellis AC (2020) Artemisinin resistance: something new or old? Something of a misnomer? Trends Parasitol 36(9):735\u2013744. https:\/\/doi.org\/10.1016\/j.pt.2020.05.013","journal-title":"Trends Parasitol"},{"key":"1682_CR63","unstructured":"WHO. 2022. World Malaria report. 1\u2013293, ISBN: 978 92 4 006489 8."},{"issue":"5","key":"1682_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01972-19","volume":"10","author":"ML Wilde","year":"2019","unstructured":"Wilde ML, Triglia T, Marapana D, Thompson JK, Kouzmitchev AA, Bullen HE et al (2019) Protein kinase A is essential for invasion of Plasmodium falciparum into human erythrocytes. Mbio 10(5):e01972-19. https:\/\/doi.org\/10.1128\/mBio.01972-19","journal-title":"Mbio"},{"key":"1682_CR65","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2015","unstructured":"World Health Organization (2015) Guidelines for the treatment of malaria, 3rd edn. World Health Organization, Geneva","edition":"3"},{"key":"1682_CR66","unstructured":"World Health Organization. 2001. In vitro micro test (mark III) for the assessment of response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine, pyrimethamine and artemisinin. CTD\/MAL\/97, 20, World Health Organization, Geneva."}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01682-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:17:15Z","timestamp":1742303835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01682-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1682"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01682-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical clearance was obtained from the IAEC (Institutional Animal Ethics Committee) (45\/GO\/ReBi\/S\/99\/CPCSEA\/PU\/IAEC\/S\/16\/50), Panjab University, Chandigarh, India.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}